These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prolonged support of working rabbit hearts using Fluosol-43 or erythrocyte media. Segel LD; Ensunsa JL; Boyle WA Am J Physiol; 1987 Feb; 252(2 Pt 2):H349-59. PubMed ID: 3812749 [TBL] [Abstract][Full Text] [Related]
26. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Kent KM; Cleman MW; Cowley MJ; Forman MB; Jaffe CC; Kaplan M; King SB; Krucoff MW; Lassar T; McAuley B Am J Cardiol; 1990 Aug; 66(3):279-84. PubMed ID: 2195864 [TBL] [Abstract][Full Text] [Related]
27. Perfluorocarbons as blood substitutes. Waxman K Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615 [TBL] [Abstract][Full Text] [Related]
28. Post-thaw recovery of cryopreserved cells. Enhanced viability by oxygenated perfluorocarbon or Pluronic F-68. Anthony P; Lowe KC; Davey MR; Power JB Adv Exp Med Biol; 1997; 428():483-8. PubMed ID: 9500088 [No Abstract] [Full Text] [Related]
29. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system. Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against reperfusion injury in ischemic rabbit lungs. Ueno T; Matsuura Y; Wada S; Murakami H; Kajihara H Transplant Proc; 1997; 29(1-2):1349-53. PubMed ID: 9123336 [No Abstract] [Full Text] [Related]
32. Enhanced post-thaw viability of cryopreserved cells by oxygenated perfluorocarbon or Pluronic F-68. Anthony P; Lowe KC; Davey MR; Power JB Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):27-33. PubMed ID: 9507754 [TBL] [Abstract][Full Text] [Related]
33. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon. Mohan C; Gennaro M; Marini C; Ascer E Am J Surg; 1992 Sep; 164(3):194-8. PubMed ID: 1329572 [TBL] [Abstract][Full Text] [Related]
34. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate. Acar C; Partington MT; Buckberg GD J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239 [TBL] [Abstract][Full Text] [Related]
35. The cardiovascular effects of the surfactant pluronic F68 in anesthetized dogs. Gosselin AM; Biro GP Adv Exp Med Biol; 1990; 277():291-9. PubMed ID: 2096635 [TBL] [Abstract][Full Text] [Related]
36. Influence of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man. Fukushima K; Nakamura M; Hinuma K Prog Clin Biol Res; 1983; 122():291-8. PubMed ID: 6878373 [No Abstract] [Full Text] [Related]
37. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Chaplin DJ; Horsman MR; Aoki DS Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549 [TBL] [Abstract][Full Text] [Related]
38. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. Mattrey RF; Andre MP Am J Cardiol; 1984 Jul; 54(1):206-10. PubMed ID: 6741815 [TBL] [Abstract][Full Text] [Related]
39. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160 [TBL] [Abstract][Full Text] [Related]
40. [Blood plasma protein adsorption capacity of perfluorocarbon emulsion stabilized by proxanol 268 (in vitro and in vivo studies)]. Sklifas AN; Zhalimov VK; Temnov AA; Kukushkin NI Biofizika; 2012; 57(2):317-24. PubMed ID: 22594289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]